Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Robertson

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Human Molecular Genetics|June 21, 2019
Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathySophie Belin, Francesca Ornaghi, Ghjuvan'Ghjacumu Shackleford, et al.
Blood|December 4, 2023
Transcriptional control of leukemogenesis by the chromatin reader SGF29Karina Barbosa, Anagha Deshpande, Marlenne Perales, et al.
Nature Communications|August 11, 2019
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancerTânia D F Costa, Ting Zhuang, Julie Lorent, et al.
Aging Cell|July 16, 2025
Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem CellsFarah Jaber-Hijazi, Rouven Arnold, Karthic Swaminathan, et al.
Cell|April 9, 2019
A Multiscale Map of the Stem Cell State in Pancreatic AdenocarcinomaNikki K Lytle, L Paige Ferguson, Nirakar Rajbhandari, et al.
JAMA|January 16, 2019
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple SclerosisJ William L Brown, Alasdair Coles, Dana Horakova, et al.
The EMBO Journal|February 10, 2019
Length-independent telomere damage drives post-mitotic cardiomyocyte senescenceRhys Anderson, Anthony Lagnado, Damien Maggiorani, et al.
The Lancet. Neurology|February 18, 2017
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort studyTomas Kalincik, J William L Brown, Neil Robertson, et al.
Plos Genetics|August 10, 2012
The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traitsBenjamin F Voight, Hyun Min Kang, Jun Ding, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Human Molecular Genetics|June 21, 2019
Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathySophie Belin, Francesca Ornaghi, Ghjuvan'Ghjacumu Shackleford, et al.
Blood|December 4, 2023
Transcriptional control of leukemogenesis by the chromatin reader SGF29Karina Barbosa, Anagha Deshpande, Marlenne Perales, et al.
Nature Communications|August 11, 2019
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancerTânia D F Costa, Ting Zhuang, Julie Lorent, et al.
Aging Cell|July 16, 2025
Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem CellsFarah Jaber-Hijazi, Rouven Arnold, Karthic Swaminathan, et al.
Cell|April 9, 2019
A Multiscale Map of the Stem Cell State in Pancreatic AdenocarcinomaNikki K Lytle, L Paige Ferguson, Nirakar Rajbhandari, et al.
JAMA|January 16, 2019
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple SclerosisJ William L Brown, Alasdair Coles, Dana Horakova, et al.
The EMBO Journal|February 10, 2019
Length-independent telomere damage drives post-mitotic cardiomyocyte senescenceRhys Anderson, Anthony Lagnado, Damien Maggiorani, et al.
The Lancet. Neurology|February 18, 2017
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort studyTomas Kalincik, J William L Brown, Neil Robertson, et al.
Plos Genetics|August 10, 2012
The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traitsBenjamin F Voight, Hyun Min Kang, Jun Ding, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Pageof 16